Search clinical trials for: Dasatinib plus Rabeprazole

Total 6416 results

Eisai Inc.

Completed

E3810-A001-313: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers

Heartburn

United States
National Taiwan University Hospital
GlaxoSmithKline

Completed

Lapatinib in Combination With Oral Vinorelbine for Metastatic Breast Cancer

Metastatic Breast Cancer

Taiwan
Shandong University
The Affiliated Hospital of Qingdao University; Qianfoshan Hospital; The Second...

Recruiting

Antineoplastic Drugs in Elderly Patients

Cancer

China
Sihuan Pharmaceutical Holdings Group Ltd.

Unknown

A Phase 3 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.

Duodenal Ulcer，DU
Eisai Inc.

Completed

A Study to Evaluate the Effect on 24-hour, Intragastric pH of RAB ER 50-mg Capsules Compared With Esomeprazole (Nexium) 40 mg Capsules and Rabeprazole (Aciphex) 20-mg Tablets

Healthy

United States
Tongji Hospital
The Second Affiliated Hospital of Fujian Medical University; Geneplus-Beijing... and other collaborators

Recruiting

Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma (CCGLC-008)

Hepatocellular Carcinoma Non-resectable

China
Jonsson Comprehensive Cancer Center
Bristol-Myers Squibb

Completed

BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib Mesylate

Leukemia

United States
Swiss Group for Clinical Cancer Research

Completed

Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors

Gastrointestinal Stromal Tumor

France, Switzerland, Germany, Finland
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Dasatinib in Treating Patients With Advanced Lung Cancer That Is No Longer Responding to Erlotinib or Gefitinib

Lung Cancer

United States
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Dasatinib in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia

Leukemia

United States
Xi'an International Medical Center Hospital

Not yet recruiting

Efficacy and Safety of Disitamab Vedotin Plus Pyrotinib or Naratinib in HER2-positive Breast Cancer Patients With Brain Metastasis

Breast Cancer

China
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Pharmacokinetic and Relative Bioavailability Study With Rabeprazole Sodium in Healthy Adult Volunteers

Gastroesophageal Reflux

United States
VA Greater Los Angeles Healthcare System
Eisai Inc.; PriCara, Unit of Ortho-McNeil, Inc.

Completed

Comparison of the Nighttime Effects of Two Different Drugs on Subjects With GERD

Gastroesophageal Reflux Disease

United States
National Taiwan University Hospital

Unknown

The Role of CYP2C19 on the Eradication of H. Pylori Infection:Implication of PK/PD Relationships

Peptic Ulcer With H. Pylori Infection | Gastritis With H. Pylori Infection

Taiwan
University Hospital, Angers

Completed

Study to Assess Dasatinib in Patients With Core Binding Factors Acute Myelogenous Leukemia (DasaCBF)

Acute Myelogenous Leukemia

France
Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Rabeprazole Sodium Delayed Release Tablets Under Fasted Conditions

Healthy

India
Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Rabeprazole Sodium Delayed Release Tablets Under Fed Conditions

Healthy

India
Chong Kun Dang Pharmaceutical

Completed

The Study to Evaluate Efficacy and Safety of Newrabell® Tab.(Rabeprazole Sodium) 10mg b.i.d in Refractory GERD

Reflux Esophagitis

Korea, Republic of
Grupo Espanol de trasplantes hematopoyeticos y...

Completed

Study of Dasatinib to Treat Philadelphia Positive Acute Lymphoblastic Leukemia (DASA-TRAS)

Leukemia, Lymphoblastic, Acute, Philadelphia-Positive

Spain
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone

Breast Cancer | Metastatic Cancer

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma

Malignant Mesothelioma

United States
Ruijin Hospital

Recruiting

A Umbrella Study in R/R PTCL Guided by Molecular Subtypes

Peripheral T Cell Lymphoma

China
Mylan Pharmaceuticals Inc

Completed

Fed Study of Rabeprazole Sodium Tablets 20 mg and Aciphex® Tablets 20 mg

Healthy

United States
Janssen-Cilag, S.A.

Terminated

Safety of Rabeprazole in Patients Under Multiple Treatments

Gastroesophageal Reflux | Gastric Ulcer
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb

Completed

A Phase I/II Study of Dasatinib and Dacarbazine

Metastatic Melanoma

United States
Jordan Collaborating Cardiology Group

Completed

Effect of Proton Pump Inhibitors on Palpitations

Signs and Symptoms

Jordan
National Taiwan University Hospital

Completed

A Comparative Study of Proton-pump Inhibitor Tests for Chinese Reflux Patients in Relation to the CYP2C19 Genotypes

GERD
The First Affiliated Hospital of Zhejiang Chinese...
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Study of Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in Unresectable Gastric Cancer

Gastric Cancer

China
Centro de Atencion e Investigacion Medica

Not yet recruiting

Bioequivalence Studies of Dasatinib 100 mg (BE-Dasatinib)

Myeloma Multiple

Colombia
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery

Melanoma (Skin)

United States
National Cancer Institute (NCI)

Completed

Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer

United States
Hospital Universitario Dr. Jose E. Gonzalez

Unknown

Low-dose Dasatinib as First-line Treatment for Chronic Myeloid Leukemia

Chronic Myelogenous Leukemia

Mexico
Kanto CML Study Group
Epidemiological and Clinical Research Information Network

Completed

A Study of Dasatinib in Patients With Imatinib Resistant or Intolerant Chronic Myeloid Leukemia

Chronic Myeloid Leukemia

Japan
Gruppo Italiano Malattie EMatologiche dell'Adulto

Active, not recruiting

Front-line Treatment of BCR-ABL+ Chronic Myeloid Leukemia (CML) With Dasatinib (CML1113)

Chronic Myeloid Leukemia

Italy
Eilean Therapeutics

Recruiting

Study of Single and Multiple Ascending Doses of ZE46-0134 in Healthy Volunteers

AML

Australia
Genentech, Inc.
Quotient Clinical

Completed

Bioavailability of GDC-0134 and the Effect of Food and Proton Pump Inhibitor on Pharmacokinetics of GDC-0134 in Healthy Female Participants

Amyotrophic Lateral Sclerosis

United Kingdom
Sihuan Pharmaceutical Holdings Group Ltd.

Completed

A Multiple Ascending High Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects

Healthy Volunteers

China
Livzon Pharmaceutical Group Inc.

Completed

Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients

Duodenal Ulcer
University of Jena

Completed

Dasatinib Holiday for Improved Tolerability (DasaHIT)

Myeloid Leukemia, Chronic

Germany
European Society for Blood and Marrow Transplantation
Bristol-Myers Squibb

Terminated

Efficacy and Safety Study of Dasatinib in Patients With Chronic Myeloid Leukemia (Dasatinib)

Chronic Myeloid Leukemia

Switzerland, United Kingdom, France, Germany
Norwegian University of Science and Technology

Completed

Safety and Efficacy of Pegylated IFN-alpha 2B Added to Dasatinib in Newly Diagnosed Chronic Phase Myeloid Leukemia (NordCML007)

Leukemia, Myeloid, Chronic-Phase

Sweden, Finland, Norway
Hamamatsu University

Completed

Comparison of Rabeprazole and Esomperazole for the Eradication of H. Pylori

H. Pylori Infection

Japan
Wan-Guang Zhang
The Second Affiliated Hospital of Fujian Medical University; Geneplus-Beijing... and other collaborators

Recruiting

Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma (CCGLC-001)

Hepatocellular Carcinoma Non-resectable

China
Nanfang Hospital of Southern Medical University

Unknown

Early Conversion of Dasatinib in CML-CP Patients

Validity and Safety

China
Kanto CML Study Group
Epidemiological and Clinical Research Information Network

Completed

A Study of Complete Molecular Response for Chronic Myeloid Leukemia in Chronic Phase Patients, Treated With Dasatinib (CMR-CML)

Chronic Myeloid Leukemia

Japan
St. Jude Children's Research Hospital
AstraZeneca; The Cure Starts Now Foundation; Tyler's Treehouse

Completed

Clinical Trial Evaluating the Combination of Vandetanib and Dasatinib During and After Radiation Therapy (RT) in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG)

Diffuse Intrinsic Pontine Glioma

United States
Translational Research Center for Medical Innovation...
Gastro-Intestinal Medical Care Research Center

Completed

Cardio-cerebrovascular Disease and Aspirin Ulcer Relapse Evaluation (CARE)

Cardio-cerebrovascular Disease

Japan
First Affiliated Hospital Xi'an Jiaotong University

Recruiting

A Study of TKI Maintenance Therapy Following Allo-HSCT in Newly Diagnosed Ph+ Adult ALL

Precursor Cell Lymphoblastic Leukemia-Lymphoma | ALL, Adult | Philadelphia-Positive Acute Lymphoblastic Leukemia

China
University of Southern California
National Cancer Institute (NCI)

Withdrawn

Dasatinib for the Treatment of Moderate and Severe COVID-19

Symptomatic COVID-19 Infection Laboratory-Confirmed

United States
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Completed

A Study of Dasatinib as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-CP)

Chronic Myelogenous Leukemia - Chronic Phase

China

Search clinical trials for: Dasatinib plus Rabeprazole

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations